Komori
Yakult Honsha (2267) · RiskReframed

Risk of restrictions on sales, supply and business activities due to COVID-19

First written in FY2020. 5 of 12 entries say "Restated". Latest entry: FY2024.

12entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2022-Q3RestatedFY2023-Q32020: 320202021: 420212022: 320222023: 120232024: 12024
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1250 companies write about · 1262 as a headwind · 6 as a tailwind

Yakult Honsha moved to the "Worse" side of this theme in 2024, 4 years after the typical company in this theme (2020).

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

27 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1276 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024ReframedAnnual report

    「The Group operates in countries and regions around the world. If a large-scale infectious disease outbreak, including an outbreak of a novel virus, occurs, domestic and overseas supply chains could be disrupted and consumption could weaken.」

    The disclosure has been reframed from specific descriptions of COVID-19 to the general infectious disease risk posed by “novel viruses and other threats.”
  2. FY2023-Q3RestatedAnnual report

    「Meanwhile, in China, activities in many districts were restricted due to lockdowns and other measures associated with the spread of COVID-19.」

    Restrictions on activities in many districts of China due to COVID-19 have continued.
  3. FY2023-Q2MaterialisedAnnual report

    「Meanwhile, in China, activities in many districts were restricted due to lockdowns and other measures associated with the spread of COVID-19.」

    Lockdowns due to the infectious disease have actually restricted sales activities in many districts in China. In Myanmar, sales and production activities have also been temporarily suspended due to political and other circumstances.
  4. FY2023-Q1MaterialisedAnnual report

    「In China, operations at the Shanghai plant and activities in many districts were restricted due to lockdowns and other measures associated with the spread of COVID-19. Following the lifting of the Shanghai lockdown in June, production at the Shanghai plant and activities in each district resumed sequentially. However, the effects of the lockdown remain, and the Company will continue responding while monitoring developments.」

    Lockdowns due to the infectious disease restricted operations at the Company's Shanghai plant and activities in various districts in China, and the effects have remained even after the restrictions were lifted.
  5. FY2022-Q3RestatedAnnual report

    「The impact of COVID-19 varies depending on the spread of infection in each country and region and on business restriction orders issued by national and local governments. The Company is taking measures in each area, conducting sales and production activities in accordance with instructions from the relevant authorities.」

    On the basis that the impact of the infectious disease differs depending on the country, region and government restriction orders, the Company continues sales and production activities in each region while taking countermeasures.
  6. FY2022-Q2RestatedAnnual report

    「The impact of COVID-19 varies depending on the spread of infection in each country and region and on business restriction orders issued by national and local governments. The Company is taking measures in each area, conducting sales and production activities in accordance with instructions from the relevant authorities.」

    On the basis that the impact of the infectious disease differs depending on the country, region and government restriction orders, the Company continues sales and production activities in each region while taking countermeasures and following instructions from the relevant authorities.
  7. FY2022-Q1RestatedAnnual report

    「The impact of COVID-19 varies depending on the spread of infection in each country and region and on business restriction orders issued by national and local governments. The Company is taking measures in each area, conducting sales and production activities in accordance with instructions from the relevant authorities.」

    On the basis that infection conditions and the impact of business restrictions differ by country and region, the Company continues sales and production activities while taking countermeasures and following instructions from the relevant authorities.
  8. FY2021MitigatedAnnual report

    「COVID-19 has still not subsided in many countries, including Japan. In the beverages and food manufacturing and sales business, the Company's main business, sales activities remain broadly normal, although sales are restricted in some areas of certain countries. Consumption has weakened in some countries due to the impact of the infectious disease, while sales volumes have increased in others as awareness of infection prevention has risen. Accordingly, the Company currently believes that COVID-19 poses no risk of a material impact on the consolidated financial statements.」

    The infectious disease outbreak and restrictions on sales and other business activities have continued, but the Company states that its main businesses have maintained broadly normal sales activities and that there is no risk of a material impact on the consolidated financial statements.
  9. FY2021-Q3RestatedAnnual report

    「COVID-19 has not yet subsided in many countries, but at present there are no restrictions on production activities at dairy product plants, and the Company believes that COVID-19 poses no risk of a material impact on the consolidated financial statements.」

    While recognizing ¥1,140 million in COVID-19-related costs, including leave compensation for Yakult Ladies affected by the infectious disease and fixed costs for professional baseball events, the Company continues to believe that there are no production restrictions at dairy product plants and no risk of a material impact on the consolidated financial statements.
  10. FY2021-Q2MitigatedAnnual report

    「COVID-19 continues to spread in some countries, but at present there are no restrictions on production activities at dairy product plants, and the Company believes that COVID-19 poses no risk of a material impact on the consolidated financial statements.」

    The impacts on sales activities, home delivery, visits to promote pharmaceuticals and professional baseball events, as well as the recognition of ¥1,137 million in COVID-19-related costs, have continued. However, there are no production restrictions at dairy product plants, and the Company states that it believes there is no risk of a material impact on the consolidated financial statements.
  11. FY2021-Q1MaterialisedAnnual report

    「Domestic sales activities were affected nationwide by the spread of COVID-19, but the Company continued its activities while working to maintain a stable supply of products and implementing measures to prevent the spread of infection.」

    The impact of the spread of COVID-19 has emerged in domestic sales activities, including the partial suspension of home delivery, the suspension of promotional tastings, a decline in vending machine sales and the recognition of ¥648 million in leave compensation.
  12. FY2020First statedAnnual report

    「The Group operates in countries and regions around the world. If a large-scale infectious disease outbreak, including COVID-19 or other novel viruses, occurs, domestic and overseas supply chains could be disrupted and consumption could weaken.」

    COVID-19 is described for the first time as a standalone major risk. The disclosure also states that impacts have already emerged in Japan and overseas, including restrictions on the activities of Yakult Ladies and delays to the opening of the professional baseball season.
Moved together

"Strengthening and Expanding the Proprietary Delivery System and Sales Organization" moved the same way as this thread, in the same document, in 3 of its 12 moves.

333322★123456
  1. ★This thread
  2. 1Strengthening and Expanding the Proprietary Delivery System and Sales Organization3×
  3. 2Cost Risk from Rising Raw Material and Crude Oil Prices3×
  4. 3Expansion of a Pharmaceutical Business Focused on Anticancer Drugs3×
  5. 4Earnings pressure on the pharmaceutical business from drug price revisions and the shift to generic drugs3×
  6. 5Research and Development of Functional, High-Value-Added Products2×
  7. 6Strengthening the Foundation of the Cosmetics Business Based on Lactic Acid Bacteria Research2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Yakult Honsha yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of restrictions on sales, supply and business activities due to COVID-19 | YAKULT HONSHA CO.,LTD. (2267) | Komori